Overview

Update
Total Equity Funding
$14M in 1 Round from 1 Investor
Most Recent Funding
$14M Series A on April 24, 2012
Headquarters:
Bridgewater, NJ
Description:
Telsar Pharma develops Astellas drugs for common inflammatory bowel diseases.
Categories:
Medical Device, Health Care, Biotechnology

Company Details

Update
Founded:
Unknown
Employees:
None found in Crunchbase

Telsar Pharma Inc., a new company that will develop an Astellas drug for a common inflammatory bowel disease.

Funding Rounds (1) - $14M

Update
DateAmount / RoundValuationLead InvestorInvestors
Apr, 2012$14M / Series A1

Investors (1)

InvestorRound(s)Partner(s)
Series A (Lead)-

News (1)

Update
DateNews
Apr 25, 2012Fierce Biotech - Telsar Pharma raises 14000000 in venture round

Offices/Locations (1)

Update
  • Headquarters

    Highway 22

    Suite 201

    Bridgewater, NJ 08807

    USA

Add Acquisitions

Add Current Team

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos